A Bill to make provision for a warning symbol to be prominently displayed on the packaging of pharmaceuticals which act on the brain and central nervous system so as to impair dangerously the consumer’s ability to carry out certainactivities; and for connected purposes.
The Bill would make provision for a warning symbol to be prominently displayed on the packaging of specified psychoactive pharmaceuticals, which act on the brain and central nervous system and which can impair dangerously the consumer’s ability to carry out certain activities.
House of Commons
9 November 2009
The bill would require a prominent warning symbol on the packaging of certain psychoactive medicines that act on the brain and central nervous system and can dangerously impair a person’s ability to carry out everyday activities. Its aim is to help people recognise when it may be unsafe to take these medicines and to protect users and others from harm.
The bill is at the second reading in the Commons, where MPs debate its general principles. If it progresses, it would go to committee for detailed examination and then to the Lords.
Generated 21 February 2026
This Bill was presented to Parliament on 26 January. This is known as First Reading and there was no debate on the Bill at this stage.
The Bill was on the Order Paper for a Second Reading on several Fridays before being dropped by its sponsor, Mr Andrew Dismore.
No recorded votes for this bill yet.
